4//SEC Filing
KAYSEN DAVID B 4
Accession 0001140361-11-032131
CIK 0000890846other
Filed
Jun 8, 8:00 PM ET
Accepted
Jun 9, 3:15 PM ET
Size
13.5 KB
Accession
0001140361-11-032131
Insider Transaction Report
Form 4
KAYSEN DAVID B
President, CEO
Transactions
- Award
common stock
2011-06-07+12,550→ 56,100 total - Award
non-qualified stock option
2011-06-07+16,350→ 16,350 totalExercise: $7.98From: 2012-06-07Exp: 2018-06-06→ common stock (16,350 underlying)
Holdings
- 50,000
non-qualified stock option
Exercise: $4.31Exp: 2012-07-02→ common stock (50,000 underlying) - 26,075
non-qualified stock option
Exercise: $4.94From: 2011-06-08Exp: 2017-06-07→ common stock (26,075 underlying) - 100,000
non-qualified stock option
Exercise: $0.85Exp: 2014-06-04→ common stock (100,000 underlying) - 50,000
non-qualified stock option
Exercise: $3.15Exp: 2013-06-23→ common stock (50,000 underlying) - 300,000
non-qualified stock option
Exercise: $2.50Exp: 2016-05-16→ common stock (300,000 underlying)
Footnotes (4)
- [F1]Includes 15,225 shares of restricted stock subject to risk of forfeiture that lapses with respect to one third of such shares on each of the second, third and fourth anniversaries of the grant date (June 8, 2010).
- [F2]Includes 12,550 shares of restricted stock subject to risk of forfeiture that lapses with respect to one fourth of such shares on each of the first, second, third and fourth anniversaries of the grant date (June 7, 2011).
- [F3]Fully vested.
- [F4]Becomes exercisable with respect to one-third of the shares on the first, second and third anniversaries of the grant date (the grant date being one year prior to such date).
Documents
Issuer
UROPLASTY INC
CIK 0000890846
Entity typeother
Related Parties
1- filerCIK 0001133026
Filing Metadata
- Form type
- 4
- Filed
- Jun 8, 8:00 PM ET
- Accepted
- Jun 9, 3:15 PM ET
- Size
- 13.5 KB